Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Blood-Borne ST6GAL1 Regulates Immunoglobulin Production in B Cells

Frontiers in Immunology(2020)10.3389/fimmu.2020.00617Source: DataRank Database

Blood-Borne ST6GAL1 Regulates Immunoglobulin Production in B Cells is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 41 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.01)OA: goldTopics (43)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Patrick R. Punch,Joseph T.Y. Lau ORCID,Eric E. Irons ORCID

Live enrichment

PubMed:32391003 PMC:PMC7190976 OpenAlex:https://openalex.org/W3018136950

NIAID NIH HHS

Grant: R01 AI140736

National Institutes of Health

Grant: 3R01AI140736-03S1

ST6Gal-1 Sialyltransferase in Inflammation

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

FWCI

2.01

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.00617/pdf

GOLDhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.00617/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.00617/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2020.00617/full

journalhttps://doi.org/10.3389/fimmu.2020.00617

Fields of Study

Immune Cell Function and InteractionGlycosylation and Glycoproteins ResearchComplement system in diseasesMedicineChemistryBiology0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

beta-D-Galactoside alpha 2-6-SialyltransferaseAnimalsB-LymphocytesImmunoglobulin GMice, Inbred C57BLSialyltransferasesN-Acetylneuraminic AcidMiceSialic Acid Binding Ig-like Lectin 2Immunity, Humoral

Keywords

AntibodyImmunoglobulin GImmunologyChemistryMedicineExtracellularB cellSialic acidSialyltransferaseIgGSt6gal ICirculating FactorRegulation – Post-transcriptionalB-LymphocytesSialic Acid Binding Ig-like Lectin 2RC581-607N-Acetylneuraminic AcidSialyltransferasesImmunity, HumoralMice, Inbred C57BLMiceAnimalsImmunologic diseases. Allergybeta-D-Galactoside alpha 2-6-Sialyltransferase

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis

10.6084/m9.figshare.22605221.v1figshare

Additional file 1 of Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis

10.6084/m9.figshare.22605221figshare